drugset / Trial / NCT02802111

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults

NCT02802111

Completed 24 enrolled Children's Hospital Los Angeles
RandomizedCrossoverSingle-blindBasic science

Summary

Albuterol is the most commonly used β agonist to treat reversible lower airway obstruction. Albuterol contains a racemic mixture of two enantiomers. Levalbuterol contains the single R form enantiomer. Levalbuterol is frequently prescribed to limit cardiovascular toxicity. The investigators sought to examine the changes in oxygen consumption (V'O2) and Heart Rate (HR) following administration of albuterol and

Timeline

Start
2015-06
Primary completion
2017-09
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Levalbuterol Other / unclassified 2.5 mg Inhaled
Subject Salbutamol Unknown 5 mg Inhaled

Indications

No indication recorded.